The forward momentum of medical progress is manifest, it could be argued, in the $50 billion spent in 2008 on pharmaceutical research and development in the quest to bring new drugs to market. But little scientific or governmental infrastructure exists to ensure that each new treatment is actually an improvement over existing therapies–and to tease out what therapies are best for which patients. [More]
If you found this reporting useful, please consider supporting our work with a small donation. Your contribution lets us continue to bring you accurate, thought-provoking science and medical news that you can trust. Independent reporting takes time, effort, and resources, and your support makes it possible for us to keep exploring the stories that matter to you. Thank you so much!